Legionella pneumophila

From WikiMD's WELLNESSPEDIA

Legionella pneumophila is a thin, aerobic, pleomorphic, flagellated, non-spore-forming, Gram-negative bacterium of the genus Legionella. It is the primary human pathogenic bacterium in this group and is the causative agent of Legionnaires' disease, also known as legionellosis.

Characteristics[edit]

Legionella pneumophila, like all Legionella species, is found in fresh water environments, such as lakes and streams. It can survive in a wide range of temperatures, but prefers temperatures between 25 and 45 degrees Celsius, with an optimum around 35 degrees Celsius. This makes it an ideal inhabitant of hot water systems, such as those found in large buildings, hotels, and hospitals.

Pathogenesis[edit]

Legionella pneumophila is a facultative intracellular parasite that can invade and replicate inside amoebae in the environment. This provides a training ground for invasion and replication in alveolar macrophages in the lung when inhaled. The bacteria use a secretion system to inject effector proteins into the host. These effectors modulate host cell functions to provide a replicative niche for the bacteria.

Diagnosis and Treatment[edit]

Diagnosis of Legionella pneumophila infection can be challenging, as it requires specific tests not commonly performed on patients with pneumonia. The most commonly used diagnostic method is the urinary antigen test, which detects the presence of Legionella antigen in the urine. Treatment typically involves antibiotics such as macrolides or quinolones.

Prevention[edit]

Prevention of Legionella pneumophila infection involves regular maintenance and disinfection of water systems, particularly in settings where the bacteria are likely to proliferate, such as hospitals and hotels. This can include heat treatment, chlorination, or the use of biocides.

See Also[edit]


Legionella_pneumophila[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.